(Q33887987)

29 July 2017

Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment (English)

1 reference

29 July 2017

1 reference

1 reference

8

Cristina Oliva

0 references

Michael Bargfrede

5

object named as

Michael Bargfrede

0 references

author name string

Karthik Venkatakrishnan

1

1 reference

29 July 2017

Yi Liu

2

1 reference

29 July 2017

Dennis Noe

3

1 reference

29 July 2017

Jaime Mertz

4

1 reference

29 July 2017

Thomas Marbury

6

1 reference

29 July 2017

Kambiz Farbakhsh

7

1 reference

29 July 2017

Ashley Milton

9

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 2014

1 reference

British Journal of Clinical Pharmacology

29 July 2017

1 reference

29 July 2017

77

1 reference

29 July 2017

6

1 reference

29 July 2017

998-1010

1 reference

Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Mifamurtide: a review of its use in the treatment of osteosarcoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Surgery and portal hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Transection of the oesophagus for bleeding oesophageal varices

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidylethanolamine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Initial clinical trial of the macrophage activator muramyl tripeptide-phosphatidylethanolamine encapsulated in liposomes in patients with advanced cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Phase I and immunomodulatory study of a muramyl peptide, muramyl tripeptide phosphatidylethanolamine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

Prediction of creatinine clearance from serum creatinine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093925

A pharmacokinetic, pharmacodynamic, and electrocardiographic study of liposomal mifamurtide (L-MTP-PE) in healthy adult volunteers.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBCP.12261

Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBCP.12261

Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24134216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24134216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/BCP.12261

1 reference

29 July 2017

1 reference

29 July 2017

1 reference